# 1. Financial Performance ## A. Key Figures * **Total Income:** **₹76.72 Cr** FY26 (+14.4%) · **₹20.35 Cr** Q4 (+4.18%) * **Margins (FY26):** **38.6%** EBITDA · **36.0%** PBT · **26.7%** PAT ## B. Revenue Growth * **Geographic Diversification:** Annual growth was underpinned by double-digit expansion in both domestic and export markets, with international sales showing particularly strong momentum. * **Sequential Acceleration:** Domestic performance strengthened significantly in the second half of the year, outpacing export growth in the same period. * **Resilient Demand:** Management successfully navigated geopolitical and supply chain headwinds by leveraging a deep product portfolio and established customer relationships. ## C. Profitability & Margins * **Operational Efficiency:** Robust margins were sustained through higher capacity utilization and supply chain optimization, effectively neutralizing inflationary pressures. * **Q4 Margin Expansion:** Quarterly profitability significantly outpaced revenue growth, with EBITDA margins reaching a high of **40.87%** due to enhanced operational discipline. * **Strategic Focus:** Future profitability is anchored in disciplined cost management and brand-building through scientific workshops and professional associations. ## D. Segment Contribution * **High-Growth Verticals:** The 3D printing portfolio emerged as a major growth driver, with resins seeing substantial double-digit gains and **Omni** brand printers surging **162%** since their recent launch. --- # 2. Product & Innovation ## A. Digital Dentistry Portfolio * **Strategic Priority:** High-priority focus on expanding 3D printing materials and next-gen hardware through in-house R&D and global partnerships. * **Competitive Positioning:** Management asserts a technological edge over major MNCs like **Dentsply**, citing a more comprehensive digital portfolio. * **Product Traction:** Rotoflex endodontic systems are seeing robust clinical adoption and increasing repeat demand from professionals. * **Ecosystem Development:** Heavy investment in the digital arena is being paired with new educational programs to drive long-term global competitiveness. ## B. R&D & Pipeline * **Advanced Pipeline:** Secured **four test licenses** for caries removal, endodontic irrigants, self-etching resins, and periodontal gels, all currently at **TRL 7**. * **Near-Term Launches:** Regulatory pathways completed for **two new products** launched this month; an additional **2 to 3 products** are slated to bolster the Oradox brand. * **Indigenous Innovation:** Actively developing a proprietary 3D printer project with a targeted commercial launch in **2028**. * **Material Science:** R&D efforts are increasingly concentrated on technologically advanced formulations and next-generation dental materials. ## C. New Vertical Performance * **Portfolio Diversification:** Successful entry into the **Disinfectant** and **Rotoflex** segments as part of a multi-step horizontal growth strategy. * **Medical-Dental Synergy:** The new Disinfectant vertical is positioned as a long-term growth driver across both dental clinics and broader medical settings. --- # 3. Manufacturing & Supply Chain ## A. Key Figures * **Traditional Line Utilization:** **67% to 68%** (Potential Turnover: **₹125 Cr** at 100%) * New Line Utilization: **18% to 20%** (Includes Digital Dentistry, Resins, Disinfectants, Oral Health) ## B. Capacity Utilization * **Significant Revenue Runway:** Traditional production lines maintain healthy utilization with substantial headroom to scale toward peak turnover capacity. * **Growth Engine Potential:** New product segments, including digital dentistry and oral health, are in the early stages of ramp-up, offering significant long-term upside as utilization improves. ## C. Import Substitution & Competitive Strategy * **Vertical Integration:** Active internal development of raw materials aims to de-risk the supply chain from foreign dependency while simultaneously capturing cost efficiencies. * **Structural Pricing Advantage:** Favorable domestic production costs combined with high import duties allow the company to compete effectively against global incumbents like **Ivoclar, Dentsply, and 3Shape**. * **Strategic R&D:** In-house material development is being positioned as both a cost-saving measure and a potential new revenue stream. --- # 4. Geography & Market Mix **A. S. Market Growth:** **37.58%** YoY · **38%** FY total ## B. Export Market Dynamics * **Global Competitive Positioning:** Leveraging the shift toward digital dentistry to compete with MNCs across **90+ countries**, bypassing traditional first-mover barriers. * **Resilient International Demand:** Achieved double-digit export expansion despite geopolitical volatility, supported by stabilizing demand in key overseas geographies. ## B. Domestic Network Expansion * **Strategic Penetration:** Focused expansion into **Tier 2 and Tier 3 cities** to capitalize on improving healthcare infrastructure and rising oral health awareness. * **Operational Recovery:** Overcame H1 headwinds from **GST changes and flooding in Jammu** to deliver a second-half performance that exceeded internal expectations. * **Sales Force Investment:** Strengthening market reach through a multi-year initiative to expand the domestic sales team and distribution network. ## C. US & UAE Subsidiaries --- # 5. Sales & Distribution ## A. Channel Strategy * **Direct-to-Clinician Push:** Leveraging the **Prevest Direct B2C program** and door-to-door outreach to sensitize doctors and bypass traditional distribution friction. * **Sales Force Expansion:** Strengthened domestic market penetration through a strategic increase in the internal field sales headcount. * **US Market Acceleration:** Aggressive regional exhibition participation is successfully converting into a dual-track growth of private labeling contracts and direct online sales. ## B. Customer Education * **Clinical Engagement:** Executed **16 structured programs** focused on restorative and digital dentistry to drive product adoption through professional technical training. ## C. Private Labeling * **OEM Scaling:** Currently servicing **3 to 4 major companies** under an OEM strategy, with a roadmap to expand this client base over the next **two years**. * **Quality Moat:** Maintaining global competitiveness and OEM eligibility through rigorous quality management certifications. --- # 6. Risks & Geopolitical Factors ## A. Key Figures * **Global Footprint:** **90 to 92** countries ## B. Logistics & Tariffs * **Operational Resilience:** Maintained disciplined execution and steady growth despite significant headwinds from global tariff developments and logistics disruptions. * **Export Headwinds:** Marginal contraction in export volumes and Oradox sales attributed to geopolitical instability and new regulatory hurdles. ## C. Regulatory Compliance * **Market Access Secured:** Successfully navigated complex international compliance by completing product registrations with **MoCRA** in the United States and the **Dubai Municipality**. ## D. Regional Instability * **Geographic Diversification:** The company utilizes its extensive global reach to mitigate regional setbacks, effectively offsetting localized sales losses with growth in alternative markets. * **Middle East Recovery:** Operations in Dubai are now active and generating business following a **two-month** delay caused by regional crises. * **Recovery Outlook:** Management expects to fully compensate for recent geopolitical-led export losses within the current fiscal year. --- # 7. Guidance & Outlook ## A. Strategic Growth & Market Expansion * **Multi-Year Growth Trajectory:** Management maintains a positive outlook for the next **2 to 3 years**, anticipating sustained top-line momentum and margin accretion in upcoming quarters. * **B. S. Market Penetration:** A core strategic pillar involves aggressive expansion in the U.S. market via **Axiodent**, alongside scaling the **Oradox Oral Care** business. * **Portfolio Diversification:** Future growth is anchored in developing the **disinfectant portfolio** into a primary business vertical and intensifying focus on high-growth segments like **3D Resins and the Rotoflex range**. ## B. Digital Workflow Adoption * **Structural Industry Shift:** Management forecasts a significant transition in clinical settings, with at least **40% of all dental office procedures** expected to adopt a digital workflow within five years. * **Innovation-Led Positioning:** The company is positioning itself as an innovation-driven partner, prioritizing **digital dentistry** and customer education to capture the shift toward modernized dental care.